Comparison

DC-Y13-27 European Partner

Manufacturer MedChem Express
Category
Type Reagents
Specific against other
Amount 5 mg
Item no. HY-154919-5mg
eClass 6.1 32160401
eClass 9.0 42051003
Available
Product Description
DC-Y13-27, a derivative of DC-Y13, is a YTHDF2 inhibitor (KD: 37.9 μM). DC-Y13-27 enhances tumor responses to radiotherapy and immunotherapy[1].
StorageTemperature
-20°C, 3 years; 4°C, 2 years (Powder)
Shipping
Room Temperature
MolecularWeight
270.31
Clinical_Information
No Development Reported
Manufacturers Research_Area
Cancer
Solubility
DMSO : 125 mg/mL (ultrasonic)
Manufacturers Target
Others
Pathway
Others
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close